Halozyme Therapeutics
HALO
#2362
Rank
HK$62.65 B
Marketcap
HK$528.23
Share price
0.48%
Change (1 day)
26.71%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): HK$3.64 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are HK$1.39 Billion. a decrease over its 2024 earnings that were of HK$4.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 HK$3.65 B-16.2%
2024 HK$4.36 B59.94%
2023 HK$2.72 B39.94%
2022 HK$1.94 B0.16%
2021 HK$1.94 B92.2%
2020 HK$1.01 B-278.96%
2019 -HK$0.57 Billion-9.45%
2018 -HK$0.63 Billion-229.51%
2017 HK$0.48 B-160.48%
2016 -HK$0.8 Billion216.03%
2015 -HK$0.26 Billion-52.86%
2014 -HK$0.54 Billion-18.09%
2013 -HK$0.66 Billion55.88%
2012 -HK$0.42 Billion169.94%
2011 -HK$0.16 Billion-63.44%
2010 -HK$0.43 Billion-7.19%
2009 -HK$0.46 Billion15.91%
2008 -HK$0.4 Billion83.89%
2007 -HK$0.22 Billion78.1%
2006 -HK$0.13 Billion16%
2005 -HK$0.11 Billion45.24%
2004 -HK$71.6 Million682.42%
2003 -HK$9.15 Million1659.12%
2002 -HK$0.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$203.48 B 5,464.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$82.95 B 2,168.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$243.78 B 6,566.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$59.98 B 1,540.37%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-HK$3.98 Billion-208.81%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
HK$11.02 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA